| Why carry out this study? |
| This review summarizes the surgical management of Fuchs endothelial corneal dystrophy (FECD). |
| What was learned from the study? |
| The surgical management of FECD has evolved over the past two decades as corneal transplantation techniques have allowed for more selective keratoplasty. |
| The current preferred surgical management of FECD is endothelial keratoplasty, which carries risks associated with the need for indefinite immunosuppression with topical steroids. |
| Descemet stripping only (DSO) involves removal of the diseased endothelium and guttae without the placement of any donor graft. |
| DSO has a very high rate of success, but requires careful patient selection. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.